Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

Cannabis Law Report

AUGUST 10, 2021

The Federal Court of Appeals in Canada ratified a Ministry of Health decision to refuse to provide J anssen Pharmaceuticals, a subsidiary of Johnson and Johnson (NYSE: JNJ ), data protection for Spravato, a ketamine analog approved for depression. What Is Data Protection And Why Is It Important? and Canada. What Happened?

Data 98

Data Pharmaceutical Treatment Medicine 98

Cannabis Law Report

JULY 5, 2021

The ERP operates as a system, collecting data in real time and connecting it all together for your. Access Control. Since the ERP is equipped with all of the company’s information, the access to data is controlled. and each user can only access part of the information. Some users can have unique privileges to.

Pharmaceutical 111

Pharmaceutical Data Access Business 111

The Cannigma

NOVEMBER 23, 2021

There is also a lack of access to healthcare professionals, and experts in the field, to guide patients through this complicated process. The app helps patients make sense of their journey by simplifying the information and supplying data-driven insights into their regimen and its effects. Music by Desca. EG: For sure. Let’s listen.

Data 52

Data Patients Access Wellness and Beauty 52

NORML

MAY 26, 2020

The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain.

Clinical Trials 252

Clinical Trials Chronic Pain Cannabinoids Patients 252

Cannabis Law Report

NOVEMBER 10, 2019

Europe Cannabis and Pain Management Devices on Cancer Pain market by key players: Cannabis Players: GW Pharmaceuticals. UNIMED PHARMACEUTICALS. Valeant Pharmaceuticals. About Us: MarketIntellica is a unique source of market research data for clients that comprise acclaimed SMEs, Chinese companies, private equity firms, and MNCs.

Pharmaceutical 45

Pharmaceutical Research and Development Data Business 45

Cannabis Law Report

JANUARY 6, 2022

An especially worrisome development is the efforts of pharmaceutical companies to patent psilocybin products. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products. Threat to Patient Access in Oregon. Relationship Between Researchers and Private Industry. info@gl-lg.com ?

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

AUGUST 17, 2021

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. We believe the totality of the data is encouraging and supports advancing to Phase 3. Data Highlights. The live webcast can be accessed here and on the investor page of Marinus’ website. About Marinus Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Project CBD

FEBRUARY 28, 2023

HerbalGram, the acclaimed quarterly journal of the American Botanical Council, recently published its 2021 “Herb Market Report,” which included data on sales of CBD as an herbal ingredient in mainstream and natural retail channels in the United States. Accessed July 25, 2021. Available at: [link] Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Puff Puff Post

DECEMBER 3, 2019

The service breaks down existing barriers for patients by providing convenient access to a broader range of options through a single source, alongside expert advice and counsel from trusted healthcare professionals. a provider of pharmaceutical products and services to long-term care facilities. TORONTO, Dec.

Access 52

Access eCommerce Wellness and Beauty Patients 52

Cannabis Law Report

AUGUST 1, 2022

Love it or hate it, social media can be a powerful tool for education and data collection.

Education 52

Education Access Media Data 52

NewsMunchies

JULY 10, 2023

With the promise of lower costs and shorter development timelines, AI-enabled drug discovery holds major potential to increase the accessibility of drugs and to treat diseases and conditions. AI automation opens up the possibility of faster, cheaper pharmaceuticals. This, in turn, makes it possible to move fast without breaking things.

Treatment 58

Treatment Research and Development Pharmaceutical Microdosing 58

Cannabis Law Report

SEPTEMBER 8, 2021

Flora will now have the ability to quickly and efficiently reference and manage information at its cultivation and extraction facility, collect and analyze data, derive insights to find cost efficiencies, and ensure accuracy. MIAMI & TORONTO–(BUSINESS WIRE)–Flora Growth Corp.

Supply Chain 95

Supply Chain Pharmaceutical Seed-To-Sale Events 95

Cannabis Law Report

NOVEMBER 16, 2021

Phase 2 trial recruiting begins immediately; efficacy data expected by the end of the first quarter of 2022. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Recruitment for the Phase 2 trial will begin immediately, and efficacy data is expected by the end of first quarter of 2022. “To MyMD Pharmaceuticals, Inc.

Pharmaceutical 52

Pharmaceutical Clinical Trials Research and Development Therapy 52

Cannabis Law Report

SEPTEMBER 24, 2019

Here is the BBC report and below you will find the full press release from GW Pharmaceuticals. The medication, developed by GW Pharmaceuticals, will be used in combination with another epilepsy medication called clobazam. What about other medical cannabis products? There are many different medical cannabis products. .

Pharmaceutical 55

Pharmaceutical Epilepsy Research and Development Medicine 55

Puff Puff Post

DECEMBER 3, 2019

The service breaks down existing barriers for patients by providing convenient access to a broader range of options through a single source, alongside expert advice and counsel from trusted healthcare professionals. a provider of pharmaceutical products and services to long-term care facilities. TORONTO, Dec.

Access 40

Access eCommerce Wellness and Beauty Patients 40

Cannabis Law Report

JANUARY 13, 2020

12, 2020 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq: GWPH), the world leader in the science, development, and commercialization of cannabinoid prescription medicines, today reported preliminary, unaudited net product sales for the fourth quarter and full-year 2019 and key priorities for 2020. Enquiries: GW Pharmaceuticals plc.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. The industry also encourages the development of novel pharmaceuticals and treatments, creating opportunities for Maryland residents to access cutting-edge healthcare options.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

JUNE 5, 2021

” Kulfas’ presentation began with some hard data, giving an account of the importance of regulating the activity in Argentina. According to Kulfas, the benefits will include: Health rights: supply of medical cannabis to ensure better access to health. ley cáñamo argentina. .” Employment: Generation of quality jobs.

Hemp 105

Hemp Research and Development Pharmaceutical Agriculture 105

Cannabis Law Report

JANUARY 17, 2022

The processes outlined in this patent application are positioned to enable scalable manufacturing because they require fewer synthetic steps than current methods, utilize cost effective and readily available starting materials, and leverage chemical manufacturing processes that are already standard practice in the pharmaceutical industry.

Research and Development 52

Research and Development Pharmaceutical Access Medicine 52

Canna Law Blog

FEBRUARY 25, 2022

If you keep a pulse on this issue, you know that for the past three years, the FDA has held the position that CBD cannot be marketed as a dietary ingredient because it was first studied and approved as a drug ingredient in GW Pharmaceuticals’ Epidiolex ( Drug Exclusion Rule ). According to NPA’s petition, the U.S.

CBD 80

CBD Safety Data Food 80

Cannabis Law Report

JUNE 5, 2019

Press Release: Thailand Government Pharmaceutical Organization. The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Google Translation.

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

United Patients Group

JANUARY 4, 2024

They bridge the gap between technology and healthcare, ensuring the secure and efficient collection, storage, analysis, and utilization of patient data. They work on implementing and maintaining electronic health records (EHRs), developing data-driven solutions, and training healthcare professionals on using technology effectively.

Research and Development 52

Research and Development Patients Data Policy 52

Cannabis Law Report

JANUARY 14, 2022

Is it a natural response to the fact that recreational is supposedly on the way or a the report suggests it’s hard as a patient to access so therefore people are just giving up. The current lack of market growth reflects an unfortunate reality in Germany that patient access to medical cannabis is still quite low.

Pharmaceutical 52

Pharmaceutical Extraction Oil Patients 52

Cannabis Law Report

JULY 20, 2022

NEW YORK , July 19, 2022 /PRNewswire/ — Data Bridge Market research has recently released expansive research titled “ Global Cannabis Seeds Market ” guarantees you will remain better informed than your competition. According to Data Bridge Market Research, Global Cannabis Seeds Market was valued at USD 1,445.05

Seed-To-Sale 52

Seed-To-Sale Research and Development Ruderalis Data 52

Cannabis Law Report

FEBRUARY 5, 2022

Review clinical protocols to ensure the collection of data needed for regulatory submissions. 5+ years’ experience in pharmaceutical industry preferably prescription medicines, narcotics, experimental drugs or products supplied via access schemes. SKILLS/QUALIFICATIONS. Minimum tertiary qualification in relevent field.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Cannabis Law Report

DECEMBER 15, 2021

Review clinical protocols to ensure the collection of data needed for regulatory submissions. 5+ years’ experience in pharmaceutical industry preferably prescription medicines, narcotics, experimental drugs or products supplied via access schemes. SKILLS/QUALIFICATIONS. Minimum tertiary qualification in relevent field.

Medicine 52

Medicine Research and Development Clinical Trials Pharmaceutical 52

Cannabis Law Report

JUNE 23, 2021

Medicann is a premier cannabis-specialized clinic, providing patients with access to local specialist doctors and pharmacists that have experience prescribing cannabis-based medication. With a strong IP portfolio, RYAH gathers deep and insightful data on the complete patient session and formulation life cycle. About RYAH Group, Inc.

Programs 100

Programs Data Events Collective 100

The Cannigma

FEBRUARY 1, 2023

Advocate for the rescheduling of cannabis to improve access to cannabis for research purposes, and scientific funding for novel cannabinoid-based cancer therapies. 36 Synthetic (pharmaceutical) cannabinoids and cancer Scientists did not rest when they learned that cannabis and cannabinoids may have anti cancer properties.

Clinical Trials 145

Clinical Trials Research and Development Therapy Cannabinoids 145

Cannabis Law Report

AUGUST 2, 2021

The nearly 3,000 participant study will capture and publish the most comprehensive data ever collected on CBD product effectiveness from 13 commercially available U.S. Radicle ACES is Institutional Review Board (IRB) approved and will capture CBD effectiveness data directly from nearly 3,000 study participants.

CBD 105

CBD Data Sleep Clinical Trials 105

Cannabis Law Report

MARCH 29, 2022

to acquire Dutch medical cannabis company APIRx Pharmaceutical BV. On the other hand, the international marketplace is far more focused on true medicinal, pharmaceutical development, infrastructure, data, formulations, and the continued development thereof.

Pharmaceutical 52

Pharmaceutical Cannabinoids Data Policy 52

Cannabis Law Report

AUGUST 12, 2021

Since 2013, medicinal cannabis has been legalized in the Czech Republic due to the amendment to the Act on pharmaceuticals, otherwise known as Act No. With medical research indicating that using the plant provides significant medical benefits, the Czech Chamber of Deputies suggested a revision to the government’s Act on pharmaceuticals.

Legalization 59

Legalization Pharmaceutical Safety Extraction 59

NORML

AUGUST 26, 2019

There are currently five “pharmaceutical processor” permit holders in Virginia, and they’re about to open for business. In Virginia, these families were simply asking to be able to possess the medicines they were able to access in other states. ” and “We only want to see data from an American source.”

Marijuana 213

Marijuana Legalization Programs Oil 213

Cannabis Law Report

JUNE 1, 2021

Given the size and scale of the study, RYAH has developed a custom software solution, using OAuth API-integration to protect the privacy of the participants in the study, with the goal of enabling a fully integrated, patient feedback and data collection capability. About RYAH Group, Inc. RYAH Group, Inc.

Clinical Trials 89

Clinical Trials Chronic Pain Data Research and Development 89

Cannabis Law Report

SEPTEMBER 20, 2021

provides Heritage and subsidiary Opticann the benefits of offering patients access to safe, convenient, and effective CB4 products developed on trusted technology platforms. The products leverage pharmaceutical technology to maximize performance and safety. TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp.

Clinical Trials 52

Clinical Trials Pharmaceutical Data Patients 52

Veriheal

JULY 22, 2021

You may have wondered what the impact of cannabis legalization would be on the illicit market and the drugs accessed there. Well, a recent study found that one of the implications involves impacting the prices in the unlicensed cannabis market as well as the illicit pharmaceutical market. increase in oxycodone prices, and a 5.1%

Legalization 52

Legalization Pharmaceutical Data Recreational 52

Veriheal

JUNE 17, 2022

Cannabis is being increasingly chosen as an alternative to pharmaceutical medication, specifically those like opioids that are intended to reduce pain. The researchers recruited certified oncologists who were able to give their patients access to medical cannabis.

Patients 98

Patients Treatment Pharmaceutical Consumption 98